See more : AGF A/S (AGF-B.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Vieworks Co., Ltd. (100120.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vieworks Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Updater Services Limited (UDS.BO) Income Statement Analysis – Financial Results
- EAT&HOLDINGS Co.,Ltd (2882.T) Income Statement Analysis – Financial Results
- Galapagos NV (GLPG) Income Statement Analysis – Financial Results
- Defence Therapeutics Inc. (DTC.CN) Income Statement Analysis – Financial Results
- Pine Cliff Energy Ltd. (PNE.TO) Income Statement Analysis – Financial Results
Vieworks Co., Ltd. (100120.KQ)
About Vieworks Co., Ltd.
Vieworks Co., Ltd. develops, manufactures, and sells imaging systems and solutions. The company offers X-ray detectors and image processing technologies for general radiography system, dental and surgical C-arm systems, radiography and fluoroscopy system, veterinary radiography system, industrial inspection instrument, and other applications. It also provides industrial cameras; and bio imaging systems comprising in vivo imaging systems under the VISQUE brand. The company was formerly known as Raysis Co., Ltd. and changed its name to Vieworks Co., Ltd. in November 2006. Vieworks Co., Ltd. was founded in 1999 and is headquartered in Anyang-si, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 220.25B | 237.93B | 193.14B | 160.26B | 136.01B | 131.40B | 123.46B | 117.30B | 93.44B | 70.81B | 66.50B | 46.82B |
| Cost of Revenue | 124.96B | 131.54B | 99.74B | 79.65B | 66.08B | 67.51B | 63.58B | 59.51B | 53.78B | 36.00B | 35.51B | 23.19B |
| Gross Profit | 95.29B | 106.38B | 93.40B | 80.62B | 69.93B | 63.89B | 59.88B | 57.80B | 39.66B | 34.82B | 30.99B | 23.63B |
| Gross Profit Ratio | 43.27% | 44.71% | 48.36% | 50.30% | 51.42% | 48.62% | 48.50% | 49.27% | 42.45% | 49.17% | 46.60% | 50.47% |
| Research & Development | 26.88B | 24.06B | 24.91B | 22.25B | 17.17B | 16.09B | 13.64B | 11.34B | 7.83B | 7.41B | 5.43B | 4.07B |
| General & Administrative | 5.05B | 4.87B | 2.84B | 2.44B | 513.53M | 437.67M | 429.51M | 369.47M | 403.55M | 324.64M | 191.22M | 208.96M |
| Selling & Marketing | 13.06B | 11.70B | 10.76B | 9.21B | 8.59B | 7.57B | 4.48B | 4.46B | 4.24B | 4.09B | 3.61B | 3.22B |
| SG&A | 18.11B | 39.37B | 33.69B | 27.80B | 25.38B | 24.16B | 16.71B | 15.04B | 12.09B | 11.20B | 10.05B | 9.81B |
| Other Expenses | 31.57B | -646.78M | -2.04B | -1.50B | -1.59B | -1.09B | -894.15M | -952.34M | -1.36B | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 76.56B | 64.07B | 60.64B | 51.55B | 44.14B | 41.34B | 31.24B | 27.33B | 21.29B | 22.20B | 19.06B | 17.37B |
| Cost & Expenses | 201.51B | 195.62B | 160.38B | 131.20B | 110.22B | 108.84B | 94.83B | 86.84B | 75.06B | 58.20B | 54.57B | 40.56B |
| Interest Income | 345.35M | 168.44M | 97.39M | 149.71M | 323.80M | 228.89M | 154.04M | 117.08M | 66.63M | 14.13M | 245.86M | 361.06M |
| Interest Expense | 2.48B | 1.07B | 387.67M | 38.05M | 67.31M | 64.45M | 9.99M | 7.88M | 21.42M | 161.24M | 0.00 | 56.23M |
| Depreciation & Amortization | 6.99B | 6.12B | 5.53B | 3.86B | 3.45B | 3.11B | 3.73B | 3.51B | 3.63B | 3.46B | 3.05B | 2.67B |
| EBITDA | 26.16B | 40.66B | 45.56B | 31.84B | 33.69B | 28.31B | 26.98B | 36.84B | 22.78B | 16.24B | 15.23B | 9.35B |
| EBITDA Ratio | 11.88% | 20.36% | 19.82% | 20.54% | 21.50% | 19.54% | 26.21% | 28.97% | 23.55% | 23.60% | 23.87% | 21.74% |
| Operating Income | 18.74B | 42.31B | 32.76B | 29.07B | 25.79B | 22.56B | 28.63B | 30.47B | 18.37B | 13.26B | 12.82B | 7.51B |
| Operating Income Ratio | 8.51% | 17.78% | 16.96% | 18.14% | 18.96% | 17.17% | 23.19% | 25.97% | 19.67% | 18.72% | 19.28% | 16.03% |
| Total Other Income/Expenses | -1.73B | -10.60B | 4.84B | -1.09B | 3.73B | 2.58B | -5.39B | 2.86B | 760.16M | -629.72M | -645.21M | -882.35M |
| Income Before Tax | 17.01B | 33.47B | 39.65B | 27.94B | 30.17B | 25.13B | 23.25B | 33.32B | 19.13B | 12.63B | 12.18B | 6.62B |
| Income Before Tax Ratio | 7.72% | 14.07% | 20.53% | 17.44% | 22.18% | 19.13% | 18.83% | 28.41% | 20.48% | 17.83% | 18.31% | 14.15% |
| Income Tax Expense | 1.93B | 6.60B | 6.11B | 5.02B | 5.84B | 4.33B | 3.63B | 6.50B | 3.36B | 2.04B | 2.76B | 1.12B |
| Net Income | 14.71B | 26.54B | 33.47B | 22.89B | 24.22B | 20.77B | 19.63B | 26.98B | 15.90B | 10.48B | 9.47B | 5.66B |
| Net Income Ratio | 6.68% | 11.15% | 17.33% | 14.28% | 17.80% | 15.81% | 15.90% | 23.00% | 17.01% | 14.80% | 14.23% | 12.10% |
| EPS | 1.60K | 2.89K | 3.58K | 2.39K | 2.46K | 2.10K | 1.97K | 2.70K | 1.59K | 1.05K | 946.00 | 566.00 |
| EPS Diluted | 1.60K | 2.89K | 3.58K | 2.39K | 2.46K | 2.10K | 1.97K | 2.70K | 1.59K | 1.05K | 946.00 | 566.00 |
| Weighted Avg Shares Out | 9.18M | 9.18M | 9.36M | 9.56M | 9.86M | 9.91M | 9.96M | 9.99M | 10.00M | 10.00M | 10.01M | 10.01M |
| Weighted Avg Shares Out (Dil) | 9.18M | 9.18M | 9.36M | 9.56M | 9.86M | 9.91M | 9.96M | 9.99M | 10.00M | 10.00M | 10.01M | 10.01M |
Source: https://incomestatements.info
Category: Stock Reports